Form 4: Charles River Laboratories Executive Reports Routine Stock Disposition for Tax Purposes

Joseph W. LaPlume, EVP of Corporate Strategy & Development at Charles River Laboratories, reported the disposition of common stock to cover tax obligations related to equity awards.

Summary

• Joseph W. LaPlume, Executive Vice President of Corporate Strategy & Development at Charles River Laboratories International, Inc. (CRL), filed a Form 4 reporting changes in his beneficial ownership of common stock.
• On May 26, 2025, Mr. LaPlume disposed of 161 shares of common stock at a price of $136.73 per share.
• On May 27, 2025, an additional 122 shares of common stock were disposed of at a price of $136.73 per share.
• On May 28, 2025, 83 shares of common stock were disposed of at a price of $138.65 per share.
• These dispositions, indicated by transaction code 'F', typically represent shares withheld by the issuer to satisfy tax withholding obligations upon the vesting of equity awards.
• Following these transactions, Mr. LaPlume directly beneficially owned 19,147 shares of Charles River Laboratories common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral. The Form 4 reports routine insider transactions (dispositions for tax withholding) which are common and expected, carrying no inherent positive or negative implications for the company's performance or outlook.

Future Outlook

This document, a Form 4, reports past insider transactions and does not contain forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This Form 4 filing details a routine insider transaction for an executive at Charles River Laboratories, a global contract research organization (CRO). Such dispositions for tax purposes are common across all industries, including the life sciences and pharmaceutical services sector, and do not typically reflect a change in the company's strategic direction or industry trends.

Stakeholder Impact

• Shareholders: The impact on shareholders is minimal as these are routine, small-scale dispositions for tax purposes and do not signal a change in management's confidence or company fundamentals.
• Employees: No direct impact on employees is indicated by this filing.
• Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated by this filing.

Key Dates

Keywords

Form 4, Insider Transaction, Stock Disposition, Tax Withholding, Equity Compensation, Charles River Laboratories, CRL, Joseph W. LaPlume, Beneficial Ownership